On today’s STOP TRADING segment on CNBC, Jim Cramer covered a few issues.
He noted Pfizer (PFE) again, saying it was another Bristol-Myers (BMY). He said it is a $25.00 bond now, that has almost no upside. Regarding the safety board, he said them not even knowing of a possibility of issues.
Going hunting, Cramer said Cabellas (CAB) is one that is winning from hunting trends again. He said the analysts also refuse to upgrade it and they might be wrong.
Cramer thinks Archer-Daniels (ADM) is a winner trading cheap.
Jon C. Ogg
December 4, 2006
Are You Ahead, or Behind on Retirement?
If you’re one of the over 4 Million Americans set to retire this year, you may want to pay attention. Many people have worked their whole lives preparing to retire without ever knowing the answer to the most important question: am I ahead, or behind on my goals?
Don’t make the same mistake. It’s an easy question to answer. A quick conversation with a financial advisor can help you unpack your savings, spending, and goals for your money. With Zoe Financial’s free matching tool, you can connect with trusted financial advisors in minutes.
Why wait? Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.